Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Neomycin, Sulfadiazine
Cross Vetpharm Group Ltd
QA07AA51
Neomycin, Sulfadiazine
Oral suspension
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Antimicrobial
Authorized
2007-06-12
Revised: January 2016 AN: 01377/2015 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Bimamix, Oral Suspension for Calves 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCES: Sulfadiazine 150 mg/ml Neomycin (as neomycin sulphate) 25 mg/ml EXCIPIENTS: Methyl Parahydroxybenzoate 2.0 mg/ml Propyl Parahydroxybenzoate 0.2 mg/ml Carmoisine E122 0.05 mg/ml For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pre-ruminant calves 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of diarrhoea in pre-ruminant calves associated with infections caused by organisms known to be, or suspected of being, susceptible to the combination of sulfadiazine and neomycin. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredient. Do not exceed the recommended dosage or the period of treatment. Do not use local anaesthetics of the procaine group during treatment as they are antagonistic to the sulphonamide component. Do not use in calves with a functional rumen. Do not use in lactating cows Do not use in foals and horses. Page 1 of 4 Revised: January 2016 AN: 01377/2015 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Concurrent intravenous fluid therapy should be considered in dehydrated calves. Parenteral antibiotic treatment should be considered if a clinical response is not seen after 48 hours treatment. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Official, national and regional antimicrobial policies should be taken into account when the product is used. Special precautions to be taken by the person administering the veterinary medicinal product to animals Care should be taken to avoid contact with the skin. Wash hands after use. Sulphonamides may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to sulphonamides may lead to cross reaction with other antibiotics. Allergic re Read the complete document